BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 17954021)

  • 1. Morphologic and functional imaging of malignant pleural mesothelioma.
    Yamamuro M; Gerbaudo VH; Gill RR; Jacobson FL; Sugarbaker DJ; Hatabu H
    Eur J Radiol; 2007 Dec; 64(3):356-66. PubMed ID: 17954021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the best way to diagnose and stage malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT.
    Huang YC; Tu DG; Wu JD; Lee MY
    Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
    Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
    Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends in radiologic management of malignant pleural mesothelioma.
    Gill RR; Gerbaudo VH; Sugarbaker DJ; Hatabu H
    Semin Thorac Cardiovasc Surg; 2009; 21(2):111-20. PubMed ID: 19822282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging before and after multimodal treatment for malignant pleural mesothelioma.
    Fiore D; Baggio V; Sotti G; Muzzio PC
    Radiol Med; 2006 Apr; 111(3):355-64. PubMed ID: 16683083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of pleural and chest wall tumors.
    Weyant MJ; Flores RM
    Thorac Surg Clin; 2004 Feb; 14(1):15-23. PubMed ID: 15382305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose.
    Ceresoli GL; Chiti A; Zucali PA; Rodari M; Lutman RF; Salamina S; Incarbone M; Alloisio M; Santoro A
    J Clin Oncol; 2006 Oct; 24(28):4587-93. PubMed ID: 17008700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
    Erasmus JJ; Truong MT; Smythe WR; Munden RF; Marom EM; Rice DC; Vaporciyan AA; Walsh GL; Sabloff BS; Broemeling LD; Stevens CW; Pisters KM; Podoloff DA; Macapinlac HA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1364-70. PubMed ID: 15942579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
    Wang ZJ; Reddy GP; Gotway MB; Higgins CB; Jablons DM; Ramaswamy M; Hawkins RA; Webb WR
    Radiographics; 2004; 24(1):105-19. PubMed ID: 14730040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of mesothelioma.
    Gill RR
    Recent Results Cancer Res; 2011; 189():27-43. PubMed ID: 21479894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mesothelioma of the pleura--diagnosis with imaging procedures].
    Layer G; van Kaick G
    Langenbecks Arch Chir Suppl Kongressbd; 1992; ():173-9. PubMed ID: 1493266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
    Lee HY; Hyun SH; Lee KS; Kim BT; Kim J; Shim YM; Ahn MJ; Kim TS; Yi CA; Chung MJ
    Ann Surg Oncol; 2010 Oct; 17(10):2787-94. PubMed ID: 20461469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and response to therapy of malignant pleural mesothelioma.
    Heelan R
    Lung Cancer; 2004 Aug; 45 Suppl 1():S59-61. PubMed ID: 15261435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and staging of malignant pleural mesothelioma].
    Sohrab S; Konietzko N
    Pneumologie; 2002 Jun; 56(6):382-7. PubMed ID: 12063622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging.
    Steinert HC; Santos Dellea MM; Burger C; Stahel R
    Lung Cancer; 2005 Jul; 49 Suppl 1():S33-5. PubMed ID: 15950798
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
    Armato SG; Labby ZE; Coolen J; Klabatsa A; Feigen M; Persigehl T; Gill RR
    Lung Cancer; 2013 Nov; 82(2):190-6. PubMed ID: 24018024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging.
    Truong MT; Marom EM; Erasmus JJ
    J Thorac Imaging; 2006 May; 21(2):146-53. PubMed ID: 16770231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
    Wilcox BE; Subramaniam RM; Peller PJ; Aughenbaugh GL; Nichols Iii FC; Aubry MC; Jett JR
    Clin Lung Cancer; 2009 Jul; 10(4):244-8. PubMed ID: 19632941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.